EUVIMEDEUVIMED entdecken
Crossref

A gain of function variant in RGS18 candidate for a familial mild bleeding syndrome

Caroline Vayne, Maguelonne Roux, Yves Gruel, Marjorie Poggi, Claire Pouplard, Franck Peiretti, David-Alexandre Trégouët, Paquita Nurden, Marie-Christine Alessi

Journal of Thrombosis and Haemostasis · 2025

DOI: 10.1016/j.jtha.2024.10.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Caroline Vayne und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haemostasis, Regional University Hospital Centre Tours, Tours, France; National Institute of Health and Medical Research UMR: Mixed Res…. Hauptthemen laut MEDLINE: Blood Platelets, Exome Sequencing, Gain of Function Mutation, Genetic Predisposition to Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Rare Diseases Foundation, French National Research Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Inherited platelet diseases are bleeding disorders characterized by either defects in platelet count or platelet function, the latter being less common and very heterogeneous. Numerous gene variants associated with abnormal receptors, granules, and signaling pathways have been reported. Despite significant advancements in our understanding, many patients still lack a precise diagnosis. OBJECTIVES: To identify the genetic basis of a novel mild bleeding syndrome in a family exhibiting a selective defect of platelet aggregation. METHODS: Our study included 6 family members across 3 generations who displayed reduced platelet aggregation in response to adenosine diphosphate, protease-activated receptor 1-activating peptide, arachidonic acid, and epinephrine but not collagen. Platelet morphology, granule content, and expression of major surface glycoproteins were all found to be normal. Whole exome sequencing was performed for affected and nonaffected family members. RESULTS: We identified RGS18, which encodes the regulator of G protein signaling (RGS) 18, as a candidate gene for the platelet function defect observed in this family. The RGS18 protein serves as a crucial negative regulator of G protein-coupled receptor signaling and coordinates the signaling pathways of natural platelet inhibitors. The heterozygous RGS18 c.643C>T, p.Arg215∗ variant was found to cosegregate among all 6 affected subjects. CONCLUSION: Truncation at Arg215 removes the S216 and S218 phosphorylation sites, which are crucial regulatory domains for RGS18 activation. The impaired platelet function is thought to arise from excessive platelet downregulation due to constitutive activation of RGS18, resulting from a loss of association of the truncated form with the 14-3-3 protein.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsExome SequencingGain of Function MutationGenetic Predisposition to DiseasePedigreePlatelet AggregationRGS ProteinsHumansBlood Platelet DisordersHemorrhageHeredityHeterozygotePhenotypePlatelet Function TestsSignal TransductionSyndrome

Stichwörter der Autor:innen

GTP-binding proteinsblood plateletsexome sequencinghemorrhageplatelet function tests

Substanzen

RGS Proteins

Autor:innen und Institutionen

  • Department of Haemostasis, Regional University Hospital Centre Tours, Tours, France; National Institute of Health and Medical Research UMR: Mixed Research Unit U1327 ISCHEMIA, Membrane Signalling and Inflammation in Rep…
  • National Institute of Health and Medical Research, Mixed Research Unit-S1166, Research Unit on Cardiovascular and Metabolic Diseases, Faculty of Health, Pitié Salpêtrière, Sorbonne University, Paris, France; Human Evolu…
  • National Institute of Health and Medical Research UMR: Mixed Research Unit U1327 ISCHEMIA, Membrane Signalling and Inflammation in Reperfusion Injuries, Faculty of Medicine, Université de Tours, Tours, France.
  • National Institute of Health and Medical Research, National Research Institute for Agriculture, Food and Environment, Research Center for Cardiovascular and Nutrition, Faculty of Medicine, Aix Marseille University, Mars…
  • National Institute of Health and Medical Research, Mixed Research Unit-S1166, Research Unit on Cardiovascular and Metabolic Diseases, Faculty of Health, Pitié Salpêtrière, Sorbonne University, Paris, France; National In…
  • Institut de Rythmologie et de Modélisation Cardiaque, Hôpital Xavier Arnozan, Service de Cardiologie, Pessac, France. Electronic address: paquita.nurden@gmail.com.

Förderung

  • Rare Diseases Foundation
  • French National Research Agency

Zitieren

APA

Vayne, C., Roux, M., Gruel, Y., Poggi, M., Pouplard, C., Peiretti, F., Trégouët, D. A., Nurden, P., & Alessi, M. C. (2025). A gain of function variant in RGS18 candidate for a familial mild bleeding syndrome. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.10.016

Vancouver

Vayne C, Roux M, Gruel Y, Poggi M, Pouplard C, Peiretti F, et al. A gain of function variant in RGS18 candidate for a familial mild bleeding syndrome. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2024.10.016

BibTeX
@article{Vayne2025,
  author = {Vayne, Caroline and Roux, Maguelonne and Gruel, Yves and Poggi, Marjorie and Pouplard, Claire and Peiretti, Franck and Trégouët, David-Alexandre and Nurden, Paquita and Alessi, Marie-Christine},
  title = {A gain of function variant in RGS18 candidate for a familial mild bleeding syndrome},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  doi = {10.1016/j.jtha.2024.10.016}
}
Kostenlos starten →